New method, through which “opens a window” even for treatment of multiple sclerosisdiscovered by American scientists.
According to international media, the scientific team tried the transplantation of specific cells of the immune system, succeeding in “hitting” the virus that causes sclerosis and reducing the symptoms to a large number of patients, who participated voluntarily in the research.
More specifically, The study involved 24 patients with multiple sclerosis, of whom 20 showed significant improvement after one year of treatment.. T-cell therapy was developed by San Francisco-based Atara Biotherapeutics, which hopes to have even better news soon.
Cells of the immune system against “glandular fever” may be the key to treating multiple sclerosis, scientists claim. As the examinations performed by the patients showed, the progression of the disease was slowed down or even reversed in some patients.
A clearly larger sample of patients is needed to complete the research. However, the first signs are very satisfactory and positive, as it concerns an incurable disease, which afflicts millions of people around the world.
The study by the San Francisco science team will also help to understand the disease, and at this level, the scientific community knows very little, especially about the causes.
Clare Walton, head of research at Multiple Sclerosis Society UK, he told New Scientist: “It is encouraging that they have seen improvements in MTR. “We have seen treatments that seem promising in the first phase or even in the second phase, but then, when we move on to the next stages, we do not have the results we want.”
Follow Skai.gr on Google News
and be the first to know all the news
